Michelle Senchyna
Chief Tech/Sci/R&D Officer chez AERIE PHARMACEUTICALS, INC.
Profil
Michelle Senchyna is currently the VP-Clinical Development & Medical Affairs at Aerie Pharmaceuticals, Inc. She previously worked as the Executive Director-Ophthalmology at Allergan, Inc. and as the Director-Clinical Development at PanOptica, Inc. Prior to her industry experience, she was an Assistant Professor at The University of Waterloo.
Dr. Senchyna received her undergraduate and doctorate degrees from McMaster University.
Postes actifs de Michelle Senchyna
Sociétés | Poste | Début |
---|---|---|
AERIE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03/02/2020 |
Anciens postes connus de Michelle Senchyna
Sociétés | Poste | Fin |
---|---|---|
ALLERGAN, INC. | Corporate Officer/Principal | - |
The University of Waterloo | Corporate Officer/Principal | - |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Corporate Officer/Principal | - |
Formation de Michelle Senchyna
McMaster University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Health Technology |